Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses

The standard regimen of the BNT162b2 mRNA vaccine for SARS-CoV-2 includes two doses administered three weeks apart. However, some public health authorities spaced these doses, raising questions about efficacy. We analyzed longitudinal humoral responses against the D614G strain and variants of concer...

Descripción completa

Detalles Bibliográficos
Autores principales: Tauzin, Alexandra, Gong, Shang Yu, Beaudoin-Bussières, Guillaume, Vézina, Dani, Gasser, Romain, Nault, Lauriane, Marchitto, Lorie, Benlarbi, Mehdi, Chatterjee, Debashree, Nayrac, Manon, Laumaea, Annemarie, Prévost, Jérémie, Boutin, Marianne, Sannier, Gérémy, Nicolas, Alexandre, Bourassa, Catherine, Gendron-Lepage, Gabrielle, Medjahed, Halima, Goyette, Guillaume, Bo, Yuxia, Perreault, Josée, Gokool, Laurie, Morrisseau, Chantal, Arlotto, Pascale, Bazin, Renée, Dubé, Mathieu, De Serres, Gaston, Brousseau, Nicholas, Richard, Jonathan, Rovito, Roberta, Côté, Marceline, Tremblay, Cécile, Marchetti, Giulia C., Duerr, Ralf, Martel-Laferrière, Valérie, Kaufmann, Daniel E., Finzi, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639412/
https://www.ncbi.nlm.nih.gov/pubmed/34953513
http://dx.doi.org/10.1016/j.chom.2021.12.004

Ejemplares similares

Ejemplares similares